Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangzi Li

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Genes & Diseases|April 6, 2026
Dendritic cell vaccines: Current research progress, challenges, and opportunitiesShilin Zhang, Shanzhao Mo, Wenxing Huang, et al.
Journal of Biomedical Nanotechnology|December 14, 2020
Recombinant Endoglin-Single-Chain Variable Fragment/ Induced Protein 10 Fusion Protein Potently Boosts the Anti-Tumor Efficacy of Adoptively Transferred TRP2-Specific CD8<sup>+</sup> CD28<sup>+</sup> Cytotoxic T Lymphocytes in MiceYangzi Li, Xiaomei Yang, Xiaoling Lu, et al.
Journal of Biomedical Nanotechnology|September 21, 2021
A Single-Chain Variable Fragment Antibody/Chemokine Fusion Protein Targeting Human Endoglin to Enhance the Anti-Tumor Activity of Cytokine-Induced Killer CellsXuandong Lin, Haixia Li, Xi Li, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 25, 2024
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustionYangzi Li, Qingya Cui, Sining Liu, et al.
Journal of Hematology & Oncology|July 3, 2026
Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironmentYangzi Li, Xuan Wang, Shangkun Zhang, et al.
Journal of Immunology Research|September 23, 2020
Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer TherapyLichen Zhu, Xiaomei Yang, Dani Zhong, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Genes & Diseases|April 6, 2026
Dendritic cell vaccines: Current research progress, challenges, and opportunitiesShilin Zhang, Shanzhao Mo, Wenxing Huang, et al.
Journal of Biomedical Nanotechnology|December 14, 2020
Recombinant Endoglin-Single-Chain Variable Fragment/ Induced Protein 10 Fusion Protein Potently Boosts the Anti-Tumor Efficacy of Adoptively Transferred TRP2-Specific CD8<sup>+</sup> CD28<sup>+</sup> Cytotoxic T Lymphocytes in MiceYangzi Li, Xiaomei Yang, Xiaoling Lu, et al.
Journal of Biomedical Nanotechnology|September 21, 2021
A Single-Chain Variable Fragment Antibody/Chemokine Fusion Protein Targeting Human Endoglin to Enhance the Anti-Tumor Activity of Cytokine-Induced Killer CellsXuandong Lin, Haixia Li, Xi Li, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 25, 2024
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustionYangzi Li, Qingya Cui, Sining Liu, et al.
Journal of Hematology & Oncology|July 3, 2026
Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironmentYangzi Li, Xuan Wang, Shangkun Zhang, et al.
Journal of Immunology Research|September 23, 2020
Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer TherapyLichen Zhu, Xiaomei Yang, Dani Zhong, et al.
Pageof 2